CVS Health (DB:CVS) - Stock Price, News & Analysis

CVS Stock Overview

CVS Health Corporation provides health solutions in the United States.

CVS fundamental analysis
Snowflake Score
Valuation	6/6
Future Growth	1/6
Past Performance	5/6
Financial Health	3/6
Dividends	5/6

Rewards

Trading at 75.7% below our estimate of its fair value

Earnings are forecast to grow 7.15% per year

Earnings grew by 93.6% over the past year

Pays a reliable dividend of 3.83%

Trading at good value compared to peers and industry

Analysts in good agreement that stock price will rise by 27.5%

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months

CVS Health Corporation Competitors

Fresenius SE KGaA

XTRA:FRE

€15.0b

Fresenius Medical Care

XTRA:FME

€10.7b

SYNLAB

XTRA:SYAB

€2.3b

Siemens Healthineers

XTRA:SHL

€57.1b

Price History & Performance

Summary of all time highs, changes and price drops for CVS Health
Historical stock prices
Current Share Price	US$64.46
52 Week High	US$74.62
52 Week Low	US$60.00
Beta	0.51
1 Month Change	-9.42%
3 Month Change	-4.39%
1 Year Change	-4.22%
3 Year Change	0.59%
5 Year Change	35.59%
Change since IPO	189.71%

Recent updates

Shareholder Returns

	CVS	DE Healthcare	DE Market
7D	-3.0%	4.1%	-1.5%
1Y	-4.2%	-0.8%	0.9%

Return vs Industry: CVS matched the German Healthcare industry which returned -3.8% over the past year.

Return vs Market: CVS underperformed the German Market which returned -0.4% over the past year.

Price Volatility

Is CVS's price volatile compared to industry and market?
CVS volatility
CVS Average Weekly Movement	3.6%
Healthcare Industry Average Movement	5.6%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.0%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: CVS has not had significant price volatility in the past 3 months.

Volatility Over Time: CVS's weekly volatility (4%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1996	259,500	Karen Lynch	www.cvshealth.com

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

CVS Health Corporation Fundamentals Summary

How do CVS Health's earnings and revenue compare to its market cap?
CVS fundamental statistics
Market cap	€81.24b
Earnings (TTM)	€7.84b
Revenue (TTM)	€335.05b

10.5x

P/E Ratio

0.2x

P/S Ratio

Is CVS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CVS income statement (TTM)
Revenue	US$356.62b
Cost of Revenue	US$303.35b
Gross Profit	US$53.28b
Other Expenses	US$44.93b
Earnings	US$8.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 01, 2024

Earnings per share (EPS)	6.62
Gross Margin	14.94%
Net Profit Margin	2.34%
Debt/Equity Ratio	78.6%

How did CVS perform over the long term?

See historical performance and comparison

Dividends

3.8%

Current Dividend Yield

37%

Payout Ratio

Does CVS pay a reliable dividends?

See CVS dividend history and benchmarks

When do you need to buy CVS by to receive an upcoming dividend?
CVS Health dividend dates
Ex Dividend Date	Apr 19 2024
Dividend Pay Date	May 01 2024
Days until Ex dividend	0 days
Days until Dividend pay date	12 days

Does CVS pay a reliable dividends?

See CVS dividend history and benchmarks

CVS Stock Overview

Rewards

Risk Analysis

CVS Health Corporation Competitors

XTRA:FRE

€15.0b

XTRA:FME

€10.7b

XTRA:SYAB

€2.3b

XTRA:SHL

€57.1b

Price History & Performance

Recent News & Updates

Upcoming dividend of US$0.67 per share

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation to Report Q1, 2024 Results on May 01, 2024

Fourth quarter dividend of US$0.67 announced

Cvs Health Approves Quarterly Dividend on the Common Stock, Payable on May 1, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Recent updates

Upcoming dividend of US$0.67 per share

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation to Report Q1, 2024 Results on May 01, 2024

Fourth quarter dividend of US$0.67 announced

Cvs Health Approves Quarterly Dividend on the Common Stock, Payable on May 1, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Executive VP recently sold €2.1m worth of stock

Full year 2023 earnings released: EPS: US$6.49 (vs US$3.16 in FY 2022)

Upcoming dividend of US$0.67 per share at 3.1% yield

CVS Health Corporation Provides Earnings Guidance for the Year 2023

CVS Health Announces Executive Changes

Robbins Geller Rudman & Dowd LLP and Aqualaw PLC Reaches Settlements in Class Action with Costco Wholesale Corporation, CVS Health Corporation, The Procter & Gamble Company, Target Corporation, Walgreen Co. and Walmart Inc

CVS Health Approves Quarterly Dividend, Payable on February 1, 2024

CVS Health Names Mark Santos as President, Aetna Medicaid

Third quarter 2023 earnings released: EPS: US$1.76 (vs US$2.60 loss in 3Q 2022)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

CVS Health Announces Executive Changes

Upcoming dividend of US$0.60 per share at 3.4% yield

CVS Health Approves Quarterly Dividend, Payable on November 1, 2023

CVS Health Corporation Updates Covid-19 Vaccine Now Available At CVS Pharmacy®

CVS Health Corporation Announces Additional Responsibilities for Executive Leadership Team Members

Senior VP recently sold €1.8m worth of stock

CVS Health Corporation to Report Q3, 2023 Results on Nov 01, 2023

New minor risk - Dividend sustainability

Second quarter 2023 earnings released: EPS: US$1.48 (vs US$2.31 in 2Q 2022)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

Court Denies CVS's Motion To Escape Discrimination Lawsuit Brought By HIV-Positive "John Doe" Plaintiffs

CVS Pharmacy Introduces New Universal Tools Collection from One+Other

CVS Health Corporation Appoints Scott Kirby to Board of Directors, Effective October 1

Cvs Health Approves Quarterly Dividend on the Common Stock of the Corporation, Payable on August 1, 2023

CVS Health Corporation to Report Q2, 2023 Results on Aug 02, 2023

President recently bought €883k worth of stock

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: EPS: US$1.67 (vs US$1.76 in 1Q 2022)

Upcoming dividend of US$0.60 per share at 3.2% yield

CVS Health Corporation to Report Q1, 2023 Results on May 03, 2023

CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion.

Full year 2022 earnings released: EPS: US$3.16 (vs US$6.00 in FY 2021)

CVS Health Corporation (NYSE:CVS) entered into a definitive agreement to acquire Oak Street Health, Inc. (NYSE:OSH) from Newlight Partners LP, General Atlantic LLC and others for $9.6 billion.

Shareholder Returns

Price Volatility

About the Company

CVS Health Corporation Fundamentals Summary

10.5x

0.2x

Earnings & Revenue

Dividends

3.8%

37%